Conexeu Sciences is trading at $3.99, down 5.23%, mainly amid broader risk-off trading, rising Treasury yields, inflation concerns and biotechnology weakness.
- No new company-specific announcement or earnings catalyst was identified for September 24, 2026; the latest company communication concerns scheduled investor conferences.
- The sector ETF is down 2.04%, and major indexes are also lower.
- Selling follows declines on September 23 and September 22, extending the recent downward trend.